March 20, 2018
Strongbridge Biopharma Announces Issuance of Patent for RECORLEV™ (levoketoconazole) for the Treatment of Cushing’s Syndrome
Media
March 18, 2018
Strongbridge Biopharma plc Announces Presentation of New Data Demonstrating That Levoketoconazole is a Potent Inhibitor of Human Enzymes Controlling Cortisol Synthesis
March 15, 2018
Nordic Nanovector to Present Preclinical Data Highlighting the Anti-tumour Effect of Humalutin® in Three Lymphoma Models at AACR 2018
March 15, 2018
Onxeo to Present Results of Two Studies Highlighting Potential of AsiDNA™ as Anti-Cancer Treatment at 2018 AACR Annual Meeting
March 15, 2018
Targovax ASA: Notice of Annual General Meeting
March 14, 2018
Onxeo Provides Financial Update
March 12, 2018
Strongbridge Biopharma plc Reports Full-Year 2017 Financial Results
March 12, 2018
Nordic Nanovector to Present at the China Healthcare Investing & Partnering Symposium in China and Stifel Nordic Healthcare Seminar in London
March 12, 2018
Altimmune Announces Pre-Clinical Data From its SparVax-L Anthrax Vaccine Program
March 12, 2018
Wilson Therapeutics announces agenda for Capital Markets Day on 21 March 2018
